ASPIRE in-home: Rationale, design, and methods of a study to evaluate the safety and eficacy of automatic insulin suspension for nocturnal hypoglycemia

Journal of Diabetes Science and Technology

Volumn 7, Issue 4, 2013, Pages 1005-1010

  Klonoff, David C ^a   Bergenstal, Richard M ^b   Garg, Satish K ^c   Bode, Bruce W ^d   Meredith, Melissa ^e   Slover, Robert H ^c   Ahmann, Andrew ^f   Welsh, John B ^g   Lee, Scott W ^g  

^a Mills Peninsula Health Services   (United States)

^b INTERNATIONAL DIABETES CENTER   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d ATLANTA DIABETES ASSOCIATES   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g MEDTRONIC INC   (United States)

Author keywords

ASPIRE; Insulin pump suspension; Low glucose suspend; Nocturnal hypoglycemia; Randomized controlled trial; Threshold suspend

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN ASPART; INSULIN LISPRO; INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOMATION; BLOOD GLUCOSE METER; BLOOD SAMPLING; CALIBRATION; CATHETER OCCLUSION; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GLYCEMIC CONTROL; HOME INTRAVENOUS THERAPY; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INTENTION TO TREAT ANALYSIS; INTRAVASCULAR CATHETER; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTICENTER STUDY; NOCTURNAL HYPOGLYCEMIA; OUTCOME ASSESSMENT; PARALLEL DESIGN; PATIENT SAFETY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCREENING; SEIZURE; STUDY DESIGN; SUSPENSION; TREATMENT DURATION; WELLBEING; YOUNG ADULT; BLOOD; CHEMICALLY INDUCED DISORDER; CIRCADIAN RHYTHM; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL; HOME CARE; HYPOGLYCEMIA; INSULIN INFUSION; METHODOLOGY; PHYSIOLOGY; SLEEP; TREATMENT OUTCOME; CHEMICALLY INDUCED; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; PROCEDURES;

ADOLESCENT; ADULT; AGED; CIRCADIAN RHYTHM; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 1; HOME CARE SERVICES; HUMANS; HYPOGLYCEMIA; INSULIN; INSULIN INFUSION SYSTEMS; MIDDLE AGED; RESEARCH DESIGN; SLEEP; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84897119803     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700424     Document Type: Article

References (14)

1. Pickup JC. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps. Diabetes Technol Ther. 2011;13(7):695-8.
2. Choudhary P, Shin J, Wang Y, Evans ML, Hammond PJ, Kerr D, Shaw JA, Pickup JC, Amiel SA. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care. 2011;34(9):2023-5.
3. Danne T, Kordonouri O, Holder M, Haberland H, Golembowski S, Remus K, Bläsig S, Wadien T, Zierow S, Hartmann R, Thomas A. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technology Ther. 2011;13(11):1129-34.
4. Ly TT, Nicholas JA, Retterath A, Davis EA, Jones TW. Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy. Diabetes Care. 2012;35(7):1462-5.
5. Agrawal P, Welsh JB, Kannard B, Askari S, Yang Q, Kaufman FR. Usage and efectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump. J Diabetes Sci Technol. 2011;5(5):1137-41.
6. Brazg RL, Bailey TS, Garg S, Buckingham BA, Slover RH, Klonof DC, Nguyen X, Shin J, Welsh JB, Lee SW. The ASPIRE study: design and methods of an in-clinic crossover trial on the eficacy of automatic insulin pump suspension in exercise-induced hypoglycemia. J Diabetes Sci Technol. 2011;5(6):1466-71
7. Garg S, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonof DC, Shin J, Welsh JB, Kaufman FR. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther. 2012;14(3):205-9.
8. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002;45(7):937-48. (Pubitemid 34762188)
9. Tanenberg RJ, Newton CA, Drake AJ. Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract. 2010;16(2):244-8.
10. Waheed N, Butt M, Dayan C. Hypoglycaemia documented with real-time continuous glucose sensing in a case of 'dead in bed' syndrome. Pract Diabetes. 2013;30(1):33-5.
11. Towler DA, Havlin CE, Craft S, Cryer P. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes. 1993;42(12):1791-8. (Pubitemid 23346416)
12. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes. 2005;54(12):3592-601. (Pubitemid 43334356)
13. Buckingham B, Chase HP, Dassau E, Cobry E, Clinton P, Gage V, Caswell K, Wilkinson J, Cameron F, Lee H, Bequette BW, Doyle FJ 3rd. Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care. 2010;33(5):1013-7.
14. Buckingham B, Cobry E, Clinton P, Gage V, Caswell K, Kunselman E, Cameron F, Chase HP. Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Technol Ther. 2009;11(2):93-7.